The pattern of interleukin-1beta (IL-1beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections

Blood. 1997 Aug 1;90(3):1101-8.

Abstract

Interleukin-1beta (IL-1beta) is considered an important mediator in the pathogenesis of septic shock or bacterial meningitis. Its activity is specifically modulated by IL-1 receptor antagonist (IL-1Ra) and IL-1 soluble receptor type II (IL-1sRII). We now describe the time-course of IL-1beta and these modulating agents in 59 patients with acute meningococcal infections, the prototype human disease of acute endotoxin exposure. Plasma IL-1beta was increased only in severe shock and normalized within 12 to 24 hours, indicating that patients were admitted in an early stage of cytokine activation. Increased IL-1beta values in cerebrospinal fluid (CSF) were confined to patients with meningitis. Plasma IL-1Ra was elevated in both shock and nonshock patients, extremely high values being measured in severe shock. High concentrations of IL-1Ra in CSF were found in meningitis. Plasma IL-1Ra peaked shortly after IL-1beta and decreased steeply in 1 to 2 days, followed by sustained moderately elevated levels in shock patients. Interestingly, IL-1sRII showed a completely different pattern. At admission, both nonshock and shock patients manifested a similar moderate increase of plasma IL-1sRII. However, during recovery plasma IL-1sRII further increased reaching maximal concentrations 3 to 5 days after admission, 1 to 2 days after normalization of IL-1Ra. In shock patients this increase was more prominent than in nonshock patients. It is hypothesized that this increase in plasma IL-1sRII can be explained by a synergistic effect of dexamethasone and endotoxin. A second interesting observation was that, unlike the pattern in plasma, IL-1sRII levels in CSF paralleled those of IL-1beta and IL-1Ra. This suggests different modulation of IL-1beta activity in the subarachnoid space and the plasma compartment. We conclude that: (1) During the early stage of meningococcal infections IL-1Ra modulates IL-1 activity, whereas during recovery IL-1sRII may be more important. (2) Modulation in CSF and in the plasma compartment are differentially regulated.

Publication types

  • Comparative Study

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Child
  • Child, Preschool
  • Dexamethasone / pharmacology
  • Dexamethasone / therapeutic use
  • Endotoxins / pharmacology
  • Female
  • Gene Expression Regulation / drug effects
  • Humans
  • Infant
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1 / biosynthesis*
  • Interleukin-1 / blood
  • Interleukin-1 / cerebrospinal fluid
  • Interleukin-1 / genetics
  • Male
  • Meningitis, Meningococcal / drug therapy
  • Meningitis, Meningococcal / genetics
  • Meningitis, Meningococcal / metabolism
  • Meningococcal Infections / drug therapy
  • Meningococcal Infections / genetics
  • Meningococcal Infections / metabolism*
  • Middle Aged
  • Receptors, Interleukin-1 / analysis
  • Receptors, Interleukin-1 / biosynthesis*
  • Receptors, Interleukin-1 / genetics
  • Receptors, Interleukin-1 Type II
  • Shock, Septic / drug therapy
  • Shock, Septic / genetics
  • Shock, Septic / metabolism
  • Sialoglycoproteins / biosynthesis*
  • Sialoglycoproteins / blood
  • Sialoglycoproteins / cerebrospinal fluid
  • Sialoglycoproteins / genetics

Substances

  • Anti-Inflammatory Agents
  • Endotoxins
  • IL1RN protein, human
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1
  • Receptors, Interleukin-1
  • Receptors, Interleukin-1 Type II
  • Sialoglycoproteins
  • Dexamethasone